FR2456731A1 - Guanidino and amino benzoate(s) and phenyl sulphonate(s) - and related cpds. inhibit protease(s) and have bacteriostatic and fungistatic activity - Google Patents
Guanidino and amino benzoate(s) and phenyl sulphonate(s) - and related cpds. inhibit protease(s) and have bacteriostatic and fungistatic activityInfo
- Publication number
- FR2456731A1 FR2456731A1 FR7912395A FR7912395A FR2456731A1 FR 2456731 A1 FR2456731 A1 FR 2456731A1 FR 7912395 A FR7912395 A FR 7912395A FR 7912395 A FR7912395 A FR 7912395A FR 2456731 A1 FR2456731 A1 FR 2456731A1
- Authority
- FR
- France
- Prior art keywords
- para
- guanidino
- substd
- meta
- cpds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 title abstract 5
- 108091005804 Peptidases Proteins 0.000 title abstract 3
- 239000004365 Protease Substances 0.000 title abstract 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title abstract 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 title 1
- 229940064734 aminobenzoate Drugs 0.000 title 1
- 230000003385 bacteriostatic effect Effects 0.000 title 1
- 230000001408 fungistatic effect Effects 0.000 title 1
- -1 phenyl sulphonate Chemical compound 0.000 title 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 2
- 102000012479 Serine Proteases Human genes 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 108010088842 Fibrinolysin Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000010933 acylation Effects 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 230000014508 negative regulation of coagulation Effects 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 229940012957 plasmin Drugs 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960002317 succinimide Drugs 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
- 229960001322 trypsin Drugs 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Substd.-arylamines and aryl-guanidines which inhibit protease (esp. serine-protease) activity and their enantiomers and acid addn. salts are new. Cpds have formula R1R2Ph-X-Y-Z (I), (where R1R2Ph-X- is known as the acylating part and -Y-2 as the acylated part of the molecule; R1 is opt. substd. guanidino (G) in position meta or para, primary amino in position meta or para, tert. amine having alkyl substituents in position para or nitro in position meta or para; R2 is alkoxy or when R1 is G then R2 may also be halo or alkyl in position meta or para according to whether the G gp. is meta or para; X is -CO- or -SO2-; Y is O, S or opt. substd. -NH-; Z is H (with the condition that when R1 is G it is in position 3 and that R2 is not halo in position 4), a cyclic group, esp. aryl (opt. substd. by guanidino, nitro or amino), a heterocyclic esp. opt. substd. pyrimidyl, morpholinyl or succinimide. R1 and R2 may also be H with the condition that they are not both H when Z does not contain a guanidino gp. Cpds. are protease inhibitors, which are particularly useful as inhibitors of serine proteases such as trypsin, plasmin and thrombin, bacteriostats and fungistats. (I) inhibit proteases by acylation of their active serine centre with the acylating part of the cpd., whilst the acylated part has excellent anticoagulant activity. The best bacteriostats have a lipophilic group on the non-acylating part and a meta- or para-guanidino gp. on the acylating part. Typical fungistats are diguanidines and cpds. have an ester gp. on the non-acylating part and a guanidino gp. on the acylating part. Activity tests are described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7912395A FR2456731A1 (en) | 1979-05-16 | 1979-05-16 | Guanidino and amino benzoate(s) and phenyl sulphonate(s) - and related cpds. inhibit protease(s) and have bacteriostatic and fungistatic activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7912395A FR2456731A1 (en) | 1979-05-16 | 1979-05-16 | Guanidino and amino benzoate(s) and phenyl sulphonate(s) - and related cpds. inhibit protease(s) and have bacteriostatic and fungistatic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2456731A1 true FR2456731A1 (en) | 1980-12-12 |
Family
ID=9225516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7912395A Withdrawn FR2456731A1 (en) | 1979-05-16 | 1979-05-16 | Guanidino and amino benzoate(s) and phenyl sulphonate(s) - and related cpds. inhibit protease(s) and have bacteriostatic and fungistatic activity |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2456731A1 (en) |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62111963A (en) * | 1985-11-12 | 1987-05-22 | Ono Pharmaceut Co Ltd | P-guanidinobenzoic acid thiophenyl ester derivative and pharmaceutical containing same |
EP0229370A1 (en) * | 1985-12-27 | 1987-07-22 | Eisai Co., Ltd. | Guanidinobenzoic ester derivative, a process for preparing same and pharmaceutical compositions containing same |
EP0222608A3 (en) * | 1985-11-12 | 1988-09-07 | Ono Pharmaceutical Co., Ltd. | Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as active ingredient |
US4843094A (en) * | 1985-11-12 | 1989-06-27 | Ono Pharmaceutical Co., Ltd. | Derivatives of p-guantidinobenzoic acid and pharmaceutical agents containing them as active ingredient |
US4937370A (en) * | 1987-06-02 | 1990-06-26 | The Procter & Gamble Company | Novel chromophores, sunscreen compositions and methods for preventing sunburn |
US5138089A (en) * | 1986-06-27 | 1992-08-11 | The Procter & Gamble Company | Chromophores, sunscreen compositions and methods for preventing sunburn |
WO1992016503A1 (en) * | 1991-03-25 | 1992-10-01 | Boehringer Mannheim Gmbh | New sulphonamides, process for preparing the same and medicaments containing these compounds |
US5229107A (en) * | 1986-06-27 | 1993-07-20 | The Procter & Gamble Company | Sunscreen agents, sunscreen compositions and methods for preventing sunburn |
US5229106A (en) * | 1986-06-27 | 1993-07-20 | The Procter & Gamble Company | Sunscreen agents, sunscreen compositions and method for preventing sunburn |
US5230874A (en) * | 1986-06-27 | 1993-07-27 | The Procter & Gamble Company | Sunscreen agents, sunscreen compositions and methods for preventing sunburn |
US5243064A (en) * | 1986-06-27 | 1993-09-07 | The Procter & Gamble Company | Chromophores, sunscreen compositions and methods for preventing sunburn |
US5247084A (en) * | 1985-11-12 | 1993-09-21 | Ono Pharmaceutical Co., Ltd. | Derivatives of p-guanidinobenzoic acid |
US5352704A (en) * | 1989-12-22 | 1994-10-04 | Banyu Pharmaceutical Co., Ltd. | Guanidinobenzene derivatives |
WO1997036861A1 (en) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | Meta-substituted phenylene sulphonamide derivatives |
WO1997036858A1 (en) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | Cyclopropyl alkanoic acid derivatives |
FR2761061A1 (en) * | 1997-03-20 | 1998-09-25 | Synthelabo | BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF |
WO2000017159A1 (en) * | 1998-09-23 | 2000-03-30 | Tularik Inc. | Arylsulfonanilide ureas |
JP3220225B2 (en) | 1992-04-10 | 2001-10-22 | 小野薬品工業株式会社 | Guanidinophenol derivatives |
EP1285911A3 (en) * | 1998-09-23 | 2003-03-26 | Tularik Inc. | Arylsulfonanilide ureas |
WO2002070468A3 (en) * | 2001-02-08 | 2003-09-04 | Rotta Research Lab | Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
US6822001B2 (en) | 2000-11-03 | 2004-11-23 | Tularik Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
WO2007143880A1 (en) * | 2006-06-09 | 2007-12-21 | Shanghai East Best Biopharmaceutical Enterprises Co., Ltd. | Compounds for preventing and treating bacterial infection and its preparation and use |
US7405227B2 (en) | 2005-07-18 | 2008-07-29 | Bipar Sciences, Inc. | Treatment of cancer |
US8048908B2 (en) | 2006-07-13 | 2011-11-01 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
US8053431B2 (en) | 2005-11-01 | 2011-11-08 | High Point Pharmaceuticals, Llc | Pharmaceutical use of substituted amides |
US8053447B2 (en) | 2006-04-07 | 2011-11-08 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
US8138342B2 (en) | 2004-10-12 | 2012-03-20 | High Point Pharmacueticals, LLC | 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds |
US8143447B2 (en) | 2006-09-05 | 2012-03-27 | Bipar Sciences, Inc. | Treatment of cancer |
US8153798B2 (en) | 2007-03-09 | 2012-04-10 | High Point Pharmaceuticals, Llc | Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors |
US8334305B2 (en) | 2007-02-23 | 2012-12-18 | High Point Pharmaceuticals, Llc | N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase |
US8383820B2 (en) | 2007-02-23 | 2013-02-26 | High Point Pharmaceuticals, Llc | N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase |
US8383683B2 (en) | 2007-04-24 | 2013-02-26 | High Point Pharmaceuticals, Llc | Pharmaceutical use of substituted amides |
GB2533925A (en) * | 2014-12-31 | 2016-07-13 | Univ Bath | Antimicrobial compounds, compositions and methods |
CN114805141A (en) * | 2021-01-27 | 2022-07-29 | 中国科学院上海药物研究所 | 4-guanidinobenzoic acid aryl ester compound and application thereof in resisting SARS-CoV-2 virus |
US11666888B2 (en) | 2018-02-05 | 2023-06-06 | Bio-Rad Laboratories, Inc. | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand |
-
1979
- 1979-05-16 FR FR7912395A patent/FR2456731A1/en not_active Withdrawn
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5247084A (en) * | 1985-11-12 | 1993-09-21 | Ono Pharmaceutical Co., Ltd. | Derivatives of p-guanidinobenzoic acid |
EP0222608A3 (en) * | 1985-11-12 | 1988-09-07 | Ono Pharmaceutical Co., Ltd. | Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as active ingredient |
US4843094A (en) * | 1985-11-12 | 1989-06-27 | Ono Pharmaceutical Co., Ltd. | Derivatives of p-guantidinobenzoic acid and pharmaceutical agents containing them as active ingredient |
JPS62111963A (en) * | 1985-11-12 | 1987-05-22 | Ono Pharmaceut Co Ltd | P-guanidinobenzoic acid thiophenyl ester derivative and pharmaceutical containing same |
US5077428A (en) * | 1985-11-12 | 1991-12-31 | Ono Pharmaceutical Co., Ltd. | Pharmacologically active derivatives of p-guanidinobenzoic acid |
US5376655A (en) * | 1985-11-12 | 1994-12-27 | Ono Pharmaceutical Co., Ltd. | Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as an active ingredient |
EP0229370A1 (en) * | 1985-12-27 | 1987-07-22 | Eisai Co., Ltd. | Guanidinobenzoic ester derivative, a process for preparing same and pharmaceutical compositions containing same |
US4801603A (en) * | 1985-12-27 | 1989-01-31 | Eisai Co., Ltd. | Guanidinobenzoic ester derivative |
US4948808A (en) * | 1985-12-27 | 1990-08-14 | Eisai Co., Ltd. | Guanidinobenzoic ester derivative |
US5229106A (en) * | 1986-06-27 | 1993-07-20 | The Procter & Gamble Company | Sunscreen agents, sunscreen compositions and method for preventing sunburn |
US5210275A (en) * | 1986-06-27 | 1993-05-11 | The Procter & Gamble Company | Chromophores, sunscreen compositions and methods for preventing sunburn |
US5229107A (en) * | 1986-06-27 | 1993-07-20 | The Procter & Gamble Company | Sunscreen agents, sunscreen compositions and methods for preventing sunburn |
US5230874A (en) * | 1986-06-27 | 1993-07-27 | The Procter & Gamble Company | Sunscreen agents, sunscreen compositions and methods for preventing sunburn |
US5243064A (en) * | 1986-06-27 | 1993-09-07 | The Procter & Gamble Company | Chromophores, sunscreen compositions and methods for preventing sunburn |
US5138089A (en) * | 1986-06-27 | 1992-08-11 | The Procter & Gamble Company | Chromophores, sunscreen compositions and methods for preventing sunburn |
US4937370A (en) * | 1987-06-02 | 1990-06-26 | The Procter & Gamble Company | Novel chromophores, sunscreen compositions and methods for preventing sunburn |
US5352704A (en) * | 1989-12-22 | 1994-10-04 | Banyu Pharmaceutical Co., Ltd. | Guanidinobenzene derivatives |
WO1992016503A1 (en) * | 1991-03-25 | 1992-10-01 | Boehringer Mannheim Gmbh | New sulphonamides, process for preparing the same and medicaments containing these compounds |
JP3220225B2 (en) | 1992-04-10 | 2001-10-22 | 小野薬品工業株式会社 | Guanidinophenol derivatives |
WO1997036861A1 (en) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | Meta-substituted phenylene sulphonamide derivatives |
WO1997036858A1 (en) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | Cyclopropyl alkanoic acid derivatives |
US5843906A (en) * | 1996-03-29 | 1998-12-01 | G. D. Searle & Co. | Meta-substituted phenylene sulphonamide derivatives |
US6677308B1 (en) | 1996-03-29 | 2004-01-13 | G. D. Searle & Co. | Meta-substituted phenylene sulphonamide derivatives |
FR2761061A1 (en) * | 1997-03-20 | 1998-09-25 | Synthelabo | BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF |
WO1998042679A1 (en) * | 1997-03-20 | 1998-10-01 | Sanofi-Synthelabo | Benzenesulphonamide derivatives, preparation and application thereof in therapy |
EP1285911A3 (en) * | 1998-09-23 | 2003-03-26 | Tularik Inc. | Arylsulfonanilide ureas |
US6583165B2 (en) | 1998-09-23 | 2003-06-24 | Tularik Inc. | Arylsulfonanilide ureas |
WO2000017159A1 (en) * | 1998-09-23 | 2000-03-30 | Tularik Inc. | Arylsulfonanilide ureas |
US7060718B2 (en) | 1998-09-23 | 2006-06-13 | Amgen Inc. | Arylsulfonanilide ureas |
CN100335461C (en) * | 1998-09-23 | 2007-09-05 | 图拉里克公司 | Arylsulfonanilide ureas |
US6214880B1 (en) | 1998-09-23 | 2001-04-10 | Tularik Inc. | Arylsulfonanilide ureas |
US6822001B2 (en) | 2000-11-03 | 2004-11-23 | Tularik Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
US7560591B2 (en) | 2001-02-08 | 2009-07-14 | Rotta Research Laboratorium S.P.A. | Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
WO2002070468A3 (en) * | 2001-02-08 | 2003-09-04 | Rotta Research Lab | Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
US7202277B2 (en) | 2001-02-08 | 2007-04-10 | Rotta Research Laboratorium S.P.A. | Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
US8138342B2 (en) | 2004-10-12 | 2012-03-20 | High Point Pharmacueticals, LLC | 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds |
US8377985B2 (en) | 2005-07-18 | 2013-02-19 | Bipar Sciences, Inc. | Treatment of cancer |
US7405227B2 (en) | 2005-07-18 | 2008-07-29 | Bipar Sciences, Inc. | Treatment of cancer |
US8053431B2 (en) | 2005-11-01 | 2011-11-08 | High Point Pharmaceuticals, Llc | Pharmaceutical use of substituted amides |
US8053447B2 (en) | 2006-04-07 | 2011-11-08 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
WO2007143880A1 (en) * | 2006-06-09 | 2007-12-21 | Shanghai East Best Biopharmaceutical Enterprises Co., Ltd. | Compounds for preventing and treating bacterial infection and its preparation and use |
US8048908B2 (en) | 2006-07-13 | 2011-11-01 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
US8143447B2 (en) | 2006-09-05 | 2012-03-27 | Bipar Sciences, Inc. | Treatment of cancer |
US8383820B2 (en) | 2007-02-23 | 2013-02-26 | High Point Pharmaceuticals, Llc | N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase |
US8334305B2 (en) | 2007-02-23 | 2012-12-18 | High Point Pharmaceuticals, Llc | N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase |
US8809540B2 (en) | 2007-02-23 | 2014-08-19 | High Point Pharmaceuticals, Llc | N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
US8153798B2 (en) | 2007-03-09 | 2012-04-10 | High Point Pharmaceuticals, Llc | Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors |
US8383683B2 (en) | 2007-04-24 | 2013-02-26 | High Point Pharmaceuticals, Llc | Pharmaceutical use of substituted amides |
GB2533925A (en) * | 2014-12-31 | 2016-07-13 | Univ Bath | Antimicrobial compounds, compositions and methods |
WO2016108045A3 (en) * | 2014-12-31 | 2016-09-15 | Swansea University | Antimicrobial compounds, compositions and methods |
US11666888B2 (en) | 2018-02-05 | 2023-06-06 | Bio-Rad Laboratories, Inc. | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand |
US12194432B2 (en) | 2018-02-05 | 2025-01-14 | Bio-Rad Laboratories, Inc. | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand |
CN114805141A (en) * | 2021-01-27 | 2022-07-29 | 中国科学院上海药物研究所 | 4-guanidinobenzoic acid aryl ester compound and application thereof in resisting SARS-CoV-2 virus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2456731A1 (en) | Guanidino and amino benzoate(s) and phenyl sulphonate(s) - and related cpds. inhibit protease(s) and have bacteriostatic and fungistatic activity | |
YU20094A (en) | 1-H-INDOL-3-ACID ACID HYDRAZIDES AS SPLA2 INHIBITORS | |
PE20040241A1 (en) | PROTEASA HIV INHIBITORS, COMPOSITIONS CONTAINING THEM AND MATERIALS FOR THEIR SYNTHESIS | |
ATE102629T1 (en) | PEPTIDE DERIVATIVES OF PLATELET AGGREGATION INHIBITOR. | |
CA1273019C (en) | Enkephalinase inhibitors | |
DK249089A (en) | BENZAMIDE COMPOUNDS USED AS PROTEASE INHIBITORS | |
ES436542A1 (en) | Benzoic acid amides for mycobacterium infections | |
ES415231A1 (en) | N-methyl-n-(3-trifluoromethylphenylmercapto)-carbamic acid dihydrobenzofuranyl esters | |
ES521480A0 (en) | A PROCEDURE TO PREPARE A BETA-LACTAMA. | |
SE7905922L (en) | N- (DIAMINOFOSFINYL) -ARYLKARBOXAMIDER | |
JPS55115878A (en) | Epoxysuccinic acid derivative | |
SE7613428L (en) | SYMMETRIC BIS CARBAMATE ASSOCIATIONS | |
WO2001070720A3 (en) | Carbocyclic side chain containing, n-substituted metalloprotease inhibitors | |
ES447320A1 (en) | Pesticidal N,N{41 -thio and dithio bis(substituted phenyl formamidines) | |
GB1436226A (en) | Heterocyclic fused-ring derivatives of tetrahydronaphthalene and related compounds | |
GB1054708A (en) | ||
FR2028991A1 (en) | Anilides having herbicidal activity | |
ES451484A1 (en) | N-(1,2,4-Triazin-5-on-4-yl)-glycines and herbicidal compositions | |
GB1247220A (en) | N-acyl-2-amino-1,3,4-thiadiazoles | |
ES435200A1 (en) | 1-imidazoyl-methanephosphonic acid esters | |
GB1191609A (en) | Use of Oxalic Acid Diamides as Stabilizers for Polyolefins | |
GB1221116A (en) | Antiseptic detergent compositions comprising n-acyl-n'-(halogenated) aryl ureas | |
FR2250475A1 (en) | Mixt. of herbicidal agents for use as selective or total herbicides - showing a much higher activity than any of the single components | |
IL50604A (en) | Herbicidal compositions containing thiocarbamates together with n-(benzenesulfonyl)thiocarbamates as antidote therefor and some novel compounds of this type | |
BG46152A3 (en) | Herbicide composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |